BioCentury
ARTICLE | Clinical News

OCU100 regulatory update

June 16, 2014 7:00 AM UTC

Ocugen said FDA granted Orphan Drug designation to OCU100 to treat retinitis pigmentosa. The company plans to start Phase I testing for OCU100, a recombinant PC4 and SFRS1-interacting protein ( PSIP1...